BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15750167)

  • 1. Smooth muscle cell proliferation index correlates with 111In-labeled antibody Z2D3 uptake in a transplant vasculopathy swine model.
    Jimenez J; Donahay T; Schofield L; Khaw BA; Johnson LL
    J Nucl Med; 2005 Mar; 46(3):514-9. PubMed ID: 15750167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo uptake of radiolabeled antibody to proliferating smooth muscle cells in a swine model of coronary stent restenosis.
    Johnson LL; Schofield LM; Verdesca SA; Sharaf BL; Jones RM; Virmani R; Khaw BA
    J Nucl Med; 2000 Sep; 41(9):1535-40. PubMed ID: 10994735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 F(ab')2 specific for the proliferating smooth muscle cells of human atheroma. Imaging with conventional and negative charge-modified antibody fragments.
    Narula J; Petrov A; Bianchi C; Ditlow CC; Lister BC; Dilley J; Pieslak I; Chen FW; Torchilin VP; Khaw BA
    Circulation; 1995 Aug; 92(3):474-84. PubMed ID: 7634463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of 111In-Z2D3 on SPECT imaging in a swine model of coronary stent restenosis correlated with cell proliferation.
    Johnson LL; Schofield LM; Weber DK; Kolodgie F; Virmani R; Khaw BA
    J Nucl Med; 2004 Feb; 45(2):294-9. PubMed ID: 14960651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells.
    Carrió I; Pieri PL; Narula J; Prat L; Riva P; Pedrini L; Pretolani E; Caruso G; Sarti G; Estorch M; Berná L; Riambau V; Matías-Guiu X; Pak C; Ditlow C; Chen F; Khaw BA
    J Nucl Cardiol; 1998; 5(6):551-7. PubMed ID: 9869476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma imaging of atherosclerotic lesions: the role of antibody affinity in in vivo target localization.
    Narula J; Petrov A; O'Donnell SM; Ditlow C; Pieslak I; Dilley J; Chen F; Khaw BA
    J Nucl Cardiol; 1996; 3(3):231-41. PubMed ID: 8805743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smooth muscle cells of the coronary arterial tunica media express tumor necrosis factor-alpha and proliferate during acute rejection of rabbit cardiac allografts.
    Tanaka H; Swanson SJ; Sukhova G; Schoen FJ; Libby P
    Am J Pathol; 1995 Sep; 147(3):617-26. PubMed ID: 7677176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive detection of atherosclerotic lesions by 99mTc-based immunoscintigraphic targeting of proliferating smooth muscle cells.
    Narula J; Petrov A; Pak KY; Ditlow C; Chen F; Khaw BA
    Chest; 1997 Jun; 111(6):1684-90. PubMed ID: 9187194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 99mTc-annexin V imaging for in vivo detection of atherosclerotic lesions in porcine coronary arteries.
    Johnson LL; Schofield L; Donahay T; Narula N; Narula J
    J Nucl Med; 2005 Jul; 46(7):1186-93. PubMed ID: 16000288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated coronary artery transplantation in pigs: a new model to study transplantation arteriosclerosis and humoral rejection.
    Tixier DB; Czer LS; Fishbein MC; Blanche C; Admon D; Amador R; Albert GD; Trento A
    J Heart Lung Transplant; 1996 Sep; 15(9):919-27. PubMed ID: 8889988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac allograft vasculopathy is abrogated by anti-CD8 monoclonal antibody therapy.
    Allan JS; Choo JK; Vesga L; Arn JS; Pins MR; Sachs DH; Madsen JC
    Ann Thorac Surg; 1997 Oct; 64(4):1019-25. PubMed ID: 9354520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scintigraphy and immunohistology of antimyosin-Fab during graft rejection.
    Breuer M; Schütz A; Engelhardt M; Hammer C; Kemkes BM
    Angiology; 1999 Jul; 50(7):563-71. PubMed ID: 10431996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of transplant vasculopathy in aortic allografts correlates with neointimal smooth muscle cell proliferative capacity and fibrocyte frequency.
    Onuta G; van Ark J; Rienstra H; Boer MW; Klatter FA; Bruggeman CA; Zeebregts CJ; Rozing J; Hillebrands JL
    Atherosclerosis; 2010 Apr; 209(2):393-402. PubMed ID: 19913790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intercellular adhesion molecule-1 induction: a sensitive and quantitative marker for cardiac allograft rejection.
    Ohtani H; Strauss HW; Southern JF; Tamatani T; Miyasaka M; Sekiguchi M; Isobe M
    J Am Coll Cardiol; 1995 Sep; 26(3):793-9. PubMed ID: 7642875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of indium-111-anti-intercellular adhesion molecule-1 monoclonal antibody in the allografted rat lung during acute rejection.
    Amano J; Hiroe M; Ohta Y; Ishiyama S; Nishikawa T; Tanaka H; Sunamori M; Suzuki A; Miyasaka M; Marumo F
    J Heart Lung Transplant; 1996 Oct; 15(10):1027-33. PubMed ID: 8913920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a combined heart and carotid artery transplant model to investigate the impact of acute rejection on cardiac allograft vasculopathy.
    Soleimani B; Fu F; Lake P; Shi VC
    J Heart Lung Transplant; 2008 Apr; 27(4):450-6. PubMed ID: 18374883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allografts.
    Koga N; Suzuki J; Kosuge H; Haraguchi G; Onai Y; Futamatsu H; Maejima Y; Gotoh R; Saiki H; Tsushima F; Azuma M; Isobe M
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2057-62. PubMed ID: 15374847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maximizing radiotracer delivery to experimental atherosclerotic lesions with high-dose, negative charge-modified Z2D3 antibody for immunoscintigraphic targeting.
    Narula J; Petrov A; Ditlow C; Pak KY; Chen FW; Khaw BA
    J Nucl Cardiol; 1997; 4(3):226-33. PubMed ID: 9199260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of platelet-derived growth factor A and B chains in human renal vascular rejection.
    Alpers CE; Davis CL; Barr D; Marsh CL; Hudkins KL
    Am J Pathol; 1996 Feb; 148(2):439-51. PubMed ID: 8579107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody and complement in transplant vasculopathy.
    Wehner J; Morrell CN; Reynolds T; Rodriguez ER; Baldwin WM
    Circ Res; 2007 Feb; 100(2):191-203. PubMed ID: 17272820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.